Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKB-121 in NASH
NCT02442687Phase 2Completed
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JKB-121 in Nonalcoholic steatohepatitis (NASH). Started Aug 2015; status: completed.
02
Drugs
JKB-121
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02442687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442687.